From Name:
From Email:
To Name:
To Email:

Optional Message:

Intermediate-risk Trials Offer Hope for TAVR in Low-risk Patients

from Healio

Results from trials of transcatheter aortic valve (TAVR) replacement in patients at intermediate surgical risk suggest that the procedure would also be reasonable for low-risk patients, an expert said at the Society for Cardiovascular Angiography and Interventions Scientific Sessions. "There are growing TAVR indications, and the volume in our cath labs are increasing, which is driven by the clinical trials that have established what these indications are," said Steven J. Yakubov, MD, FACC, FSCAI, John H. McConnell chair of advanced structural heart disease; system chief of OhioHealth Structural Heart Disease and medical director of OhioHealth Research Institute. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063